首页 > 市场调查报告书 > 製药

基因治疗学和RNAi 以基因为基之药物开发

市场调查报告书

商品编码

1561058

CRISPR 技术市场规模、份额、成长分析、按产品类型、按应用、按地区 - 产业预测，2024-2031 年

CRISPR Technology Market Size, Share, Growth Analysis, By Product Type (Products, Services), By Application (Biomedical, Industrial), By Application (Pharma & Biopharma Companies, Biotechnology Companies), By Region - Industry Forecast 2024-2031

出版日期: 2024年09月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年CRISPR技术的全球市场规模估值为30亿美元，从2023年的35亿美元增长到2031年的118.6亿美元，预计在预测期内（2024-2031年）复合年增长率为16.50。％。

全球CRISPR技术市场是生物技术领域快速发展且前景看好的领域。 CRISPR 代表成簇规则间隔短回文重复序列，是一种革命性的基因编辑工具，可以对生物体的 DNA 进行精确的改变。这项创新技术因其解决遗传疾病、推进治疗方法开发和改变农业实践的潜力而引起了人们的极大兴趣。 CRISPR 市场经历了显着成长，预计在不久的将来将继续扩大。有几个因素促成了这种增长，包括对个人化医疗的需求不断增加、基因治疗的进步以及遗传疾病盛行率的增加。 CRISPR技术与药物发现、市场开拓和诊断工具创建的整合正在进一步加速市场扩张。此外，在工业生物技术中，CRISPR 被用于生物工程和生物製造，以创造新的酵素、生质燃料和特殊化学品，作为传统製造方法的永续替代品。总体而言，CRISPR 技术市场正在迅速发展，并有潜力彻底改变医疗保健、农业和工业生物技术等各个领域。其应用具有增强人类健康、改善食品生产和推动永续製造方法的潜力。随着研究和开发的进展，解决伦理和监管问题对于确保 CRISPR 技术的负责任和有益的使用至关重要。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Thermo Fisher Scientific Inc.（US）
Merck KGaA（Germany）
Integrated DNA Technologies（Danaher Corporation）（US）
Agilent Technologies Inc.（US）
Genscript Biotech Corp（China）
New England Biolabs Inc.（US）
Cellecta Limited（US）
GeneCopoeia Inc.（US）
Origene Technologies Inc.（US）
Editas Medicine, Inc.（US）
CRISPR Therapeutics AG（Switzerland）
Intellia Therapeutics, Inc.（US）
Illumina, Inc.（US）
Base Genomics Inc.（US）
Synthego Corporation（US）
Prime Medicine, Inc.（US）
Arbor Biotechnologies（US）
Excision BioTherapeutics, Inc.（US）
Mammoth Biosciences, Inc.（US）

简介目录

Product Code: SQMIG35H2108

Global CRISPR Technology Market size was valued at USD 3.0 billion in 2022 and is poised to grow from USD 3.50 billion in 2023 to USD 11.86 billion by 2031, growing at a CAGR of 16.50% during the forecast period (2024-2031).

The global CRISPR technology market is a rapidly developing and promising area within biotechnology. CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, represents a revolutionary gene-editing tool that enables precise alterations to the DNA of living organisms. This innovative technology has captured significant interest due to its potential to address genetic disorders, drive advancements in therapeutic development, and transform agricultural practices. The CRISPR market has experienced notable growth and is projected to continue expanding in the near future. Several factors contribute to this growth, including the rising demand for personalized medicine, progress in gene therapy, and the increasing prevalence of genetic disorders. The integration of CRISPR technology into drug discovery, development, and diagnostic tool creation has further accelerated market expansion. Additionally, the industrial biotechnology sector is utilizing CRISPR for bioengineering and bio-manufacturing, enabling the creation of novel enzymes, biofuels, and specialty chemicals that offer sustainable alternatives to conventional manufacturing methods. Overall, the CRISPR technology market is evolving rapidly with the potential to revolutionize various fields, including healthcare, agriculture, and industrial biotechnology. Its applications hold promise for enhancing human health, improving food production, and advancing sustainable manufacturing practices. As research and development continue to progress, addressing ethical and regulatory concerns will be essential to ensure the responsible and beneficial use of CRISPR technology moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global CRISPR Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global CRISPR Technology Market Segmental Analysis

Global CRISPR Technology Market is segmented by Product Type, Application, and region. Based on Product Type, the market is segmented into Products [CRISPR Libraries, CRISPR Kits & Enzymes, Other Products], Services [Cell Line Engineering, gRNA Design & Vector Consultation, Screening Services, Other Services]. Based on Application, the market is segmented into Biomedical, Industrial, Agricultural, and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global CRISPR Technology Market

Governments worldwide have significantly ramped up their funding and investment in CRISPR technology, creating a supportive environment for research and development. This increased financial backing has facilitated groundbreaking discoveries and accelerated advancements in the field, fostering a dynamic market for CRISPR innovations. As a result, the enhanced investment in CRISPR technology has led to a more vibrant and promising sector, driving progress and expanding opportunities within biotechnology. This support from government bodies is crucial for advancing research efforts and bringing transformative CRISPR-based solutions to fruition.

Restraints in the Global CRISPR Technology Market

The gene editing field faces significant technical challenges associated with CRISPR technology. Despite its considerable potential, several hurdles impede its broader application, including the complexity of achieving precise genome modifications, managing off-target effects, and ensuring effective delivery mechanisms. Addressing these technical issues is crucial for CRISPR technology to fulfill its transformative potential across various industries. Overcoming these obstacles will be key to unlocking the full benefits of CRISPR and advancing its use in a wide range of applications.

Market Trends of the Global CRISPR Technology Market

A notable trend in the CRISPR technology market is the growing integration of CRISPR in drug discovery and development. Pharmaceutical and biotechnology companies are increasingly leveraging CRISPR to streamline the drug discovery process, enhance target identification and validation, and improve both preclinical and clinical studies. CRISPR-based screening platforms facilitate more efficient identification and validation of drug targets, which contributes to the development of more effective therapies. Furthermore, CRISPR enables the creation of advanced disease models and organoids, aiding in the study of disease mechanisms and the evaluation of potential drug candidates. In addition to its impact on drug discovery, CRISPR technology is also making strides in agriculture and food production, as well as in the development of CRISPR-based diagnostics. The emphasis on ethical and regulatory considerations is also growing, reflecting a broader awareness of the implications of CRISPR technology. These trends underscore the expanding potential of CRISPR across multiple industries, highlighting its transformative capabilities and the ongoing evolution of its applications.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

CRISPR Technology Market by Product Type

Market Overview
Products
- CRISPR Libraries
- CRISPR Kits & Enzymes
- Other Products
Services
- Cell Line Engineering
- gRNA Design & Vector Consultation
- Screening Services
- Other Services

CRISPR Technology Market by Application

Market Overview
Biomedical
Industrial
Agricultural
Other Applications

CRISPR Technology Market by End-User

Market Overview
Pharma & Biopharma Companies
Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations

CRISPR Technology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies (Danaher Corporation) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corp (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellecta Limited (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneCopoeia Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Origene Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Editas Medicine, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CRISPR Therapeutics AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intellia Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Base Genomics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthego Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prime Medicine, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arbor Biotechnologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Excision BioTherapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mammoth Biosciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments